Amyloid-beta isoform metabolism quantitation by stable isotope-labeled kinetics

Analytical Biochemistry

Volumn 440, Issue 1, 2013, Pages 56-62

  Mawuenyega, Kwasi G ^a   Kasten, Tom ^a   Sigurdson, Wendy ^a   Bateman, Randall J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Amyloid beta isoforms; Cerebrospinal fluid; Mass spectrometry; Relative quantitation

Indexed keywords

BRAIN; CELL CULTURE; GLYCOPROTEINS; MASS SPECTROMETRY; METABOLISM; NEURODEGENERATIVE DISEASES; PEPTIDES;

ALZHEIMER'S DISEASE; C-TERMINAL PEPTIDES; CENTRAL NERVOUS SYSTEMS; HUMAN CEREBROSPINAL FLUID; ISOFORMS; LOW LIMITS OF DETECTIONS; RELATIVE QUANTITATIONS; THERAPEUTIC TREATMENTS;

CEREBROSPINAL FLUID;

AMYLOID BETA PROTEIN[1-42];

ARTICLE; CELL CULTURE; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; LIMIT OF DETECTION; MEASUREMENT ACCURACY; PRIORITY JOURNAL; PROTEIN METABOLISM; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; STANDARD;

EID: 84879836303     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2013.04.031     Document Type: Article

References (28)

1. J. Hardy, D.J. Selkoe, The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics, Science 297 (2002) 353-356. (Pubitemid 34790756)
2. T. Iwatsubo, A. Odaka, N. Suzuki, H. Mizusawa, N. Nukina, Y. Ihara, Visualization of Ab42(43) and Ab40 in senile plaques with end-specific Ab monoclonals: evidence that an initially deposited species is Ab42(43), Neuron 13 (1994) 45-53.
3. A. Goate, M.C. Chartier-Harlin, M. Mullan, J. Brown, F. Crawford, L. Fidani, L. Giuffra, A. Haynes, N. Irving, L. James, et al., Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease, Nature 349 (1991) 704-706. (Pubitemid 21912142)
4. E. Levy-Lahad, E.M. Wijsman, E. Nemens, L. Anderson, K.A. Goddard, J.L. Weber, T.D. Bird, G.D. Schellenberg, A familial Alzheimer's disease locus on chromosome 1, Science 269 (1995) 970-973.
5. A. Rovelet-Lecrux, D. Hannequin, G. Raux, N. Le Meur, A. Laquerriere, A. Vital, C. Dumanchin, S. Feuillette, A. Brice, M. Vercelletto, F. Dubas, T. Frebourg, D. Campion, APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy, Nat. Genet. 38 (2006) 24-26. (Pubitemid 43011878)
6. H. Welander, J. Franberg, C. Graff, E. Sundstrom, B. Winblad, L.O. Tjernberg, Ab43 is more frequent than Ab40 in amyloid plaque cores from Alzheimer disease brains, J. Neurochem. 110 (2009) 697-706.
7. T.C. Saido, T. Iwatsubo, D.M. Mann, H. Shimada, Y. Ihara, S. Kawashima, Dominant and differential deposition of distinct beta-Amyloid peptide species, AbN3(pE), in senile plaques, Neuron 14 (1995) 457-466.
8. A.E. Roher, J.D. Lowenson, S. Clarke, C. Wolkow, R. Wang, R.J. Cotter, I.M. Reardon, H.A. Zurcher-Neely, R.L. Heinrikson, M.J. Ball, et al., Structural alterations in the peptide backbone of beta-Amyloid core protein may account for its deposition and stability in Alzheimer's disease, J. Biol. Chem. 268 (1993) 3072-3083. (Pubitemid 23070928)
9. S. Kumar-Singh, J. Theuns, B. Van Broeck, D. Pirici, K. Vennekens, E. Corsmit, M. Cruts, B. Dermaut, R. Wang, C. Van Broeckhoven, Mean age-of-onset of familial Alzheimer disease caused by presenilin mutations correlates with both increased Ab42 and decreased Ab40, Hum. Mutat. 27 (2006) 686-695.
10. E. Portelius, A. Westman-Brinkmalm, H. Zetterberg, K. Blennow, Determination of beta-Amyloid peptide signatures in cerebrospinal fluid using immunoprecipitation-mass spectrometry, J. Proteome Res. 5 (2006) 1010-1016.
11. A. Halim, G. Brinkmalm, U. Ruetschi, A. Westman-Brinkmalm, E. Portelius, H. Zetterberg, K. Blennow, G. Larson, J. Nilsson, Site-specific characterization of threonine, serine, and tyrosine glycosylations of amyloid precursor protein/amyloid-beta peptides in human cerebrospinal fluid, Proc. Natl. Acad. Sci. USA 108 (2011) 11848-11853.
12. R. Vassar, B.D. Bennett, S. Babu-Khan, S. Kahn, E.A. Mendiaz, P. Denis, D.B. Teplow, S. Ross, P. Amarante, R. Loeloff, Y. Luo, S. Fisher, J. Fuller, S. Edenson, J. Lile, M.A. Jarosinski, A.L. Biere, E. Curran, T. Burgess, J.C. Louis, F. Collins, J. Treanor, G. Rogers, M. Citron, β-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE, Science 286 (1999) 735-741.
13. E. Portelius, G. Brinkmalm, A.J. Tran, H. Zetterberg, A. Westman-Brinkmalm, K. Blennow, Identification of novel APP/Ab isoforms in human cerebrospinal fluid, Neurodegener. Dis. 6 (2009) 87-94.
14. E. Portelius, H. Zetterberg, R.A. Dean, A. Marcil, P. Bourgeois, M. Nutu, U. Andreasson, E. Siemers, K.G. Mawuenyega, W.C. Sigurdson, P.C. May, S.M. Paul, D.M. Holtzman, K. Blennow, R.J. Bateman, Ab1-15/16 as a marker for c-secretase inhibition in Alzheimer's disease, J. Alzheimers Dis. 31 (2012) 335-341.
15. D.J. Selkoe, Alzheimer's disease: genes, proteins, and therapy, Physiol. Rev. 81 (2001) 741-766. (Pubitemid 32267077)
16. J. Wiltfang, H. Esselmann, M. Bibl, A. Smirnov, M. Otto, S. Paul, B. Schmidt, H.W. Klafki, M. Maler, T. Dyrks, M. Bienert, M. Beyermann, E. Ruther, J. Kornhuber, Highly conserved and disease-specific patterns of carboxyterminally truncated Ab peptides 1-37/38/39 in addition to 1-40/42 in Alzheimer's disease and in patients with chronic neuroinflammation, J. Neurochem. 81 (2002) 481-496. (Pubitemid 34809327)
17. E. Portelius, A.J. Tran, U. Andreasson, R. Persson, G. Brinkmalm, H. Zetterberg, K. Blennow, A. Westman-Brinkmalm, Characterization of amyloid beta peptides in cerebrospinal fluid by an automated immunoprecipitation procedure followed by mass spectrometry, J. Proteome Res. 6 (2007) 4433-4439. (Pubitemid 350158518)
18. J.T. Jarrett, E.P. Berger, P.T. Lansbury Jr., The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease, Biochemistry 32 (1993) 4693-4697. (Pubitemid 23162022)
19. S.A. Gravina, L. Ho, C.B. Eckman, K.E. Long, L. Otvos Jr., L.H. Younkin, N. Suzuki, S.G. Younkin, Amyloid beta protein (Ab) in Alzheimer's disease brain: biochemical and immunocytochemical analysis with antibodies specific for forms ending at Ab40 or Ab42(43), J. Biol. Chem. 270 (1995) 7013-7016.
20. A. Jan, O. Gokce, R. Luthi-Carter, H.A. Lashuel, The ratio of monomeric to aggregated forms of Ab40 and Ab42 is an important determinant of amyloidbeta aggregation, fibrillogenesis, and toxicity, J. Biol. Chem. 283 (2008) 28176-28189.
21. R.J. Bateman, L.Y. Munsell, J.C. Morris, R. Swarm, K.E. Yarasheski, D.M. Holtzman, Human amyloid-beta synthesis and clearance rates as measured in cerebrospinal fluid in vivo, Nat. Med. 12 (2006) 856-861. (Pubitemid 44050079)
22. R.J. Bateman, L.Y. Munsell, X. Chen, D.M. Holtzman, K.E. Yarasheski, Stable isotope labeling tandem mass spectrometry (SILT) to quantify protein production and clearance rates, J. Am. Soc. Mass Spectrom. 18 (2007) 997-1006. (Pubitemid 46755574)
23. K.G. Mawuenyega, W. Sigurdson, V. Ovod, L. Munsell, T. Kasten, J.C. Morris, K.E. Yarasheski, R.J. Bateman, Decreased clearance of CNS beta-Amyloid in Alzheimer's disease, Science 330 (2010) 1774.
24. R.B. DeMattos, J.R. Cirrito, M. Parsadanian, P.C. May, M.A. O'Dell, J.W. Taylor, J.A. Harmony, B.J. Aronow, K.R. Bales, S.M. Paul, D.M. Holtzman, ApoE and clusterin cooperatively suppress Ab levels and deposition: evidence that ApoE regulates extracellular Ab metabolism in vivo, Neuron 41 (2004) 193-202. (Pubitemid 38125181)
25. M.E. Lame, E.E. Chambers, M. Blatnik, Quantitation of amyloid beta peptides Ab(1-38), Ab(1-40), and Ab(1-42) in human cerebrospinal fluid by ultraperformance liquid chromatography-Tandem mass spectrometry, Anal. Biochem. 419 (2011) 133-139.
26. K. Watanabe, C. Ishikawa, H. Kuwahara, K. Sato, S. Komuro, T. Nakagawa, N. Nomura, S. Watanabe, M. Yabuki, A new methodology for simultaneous quantification of total-Ab, Abx-38, Abx-40, and Abx-42 by column-switching LC/MS/MS, Anal. Bioanal. Chem. 402 (2012) 2033-2042.
27. N. Taouatas, M.M. Drugan, A.J. Heck, S. Mohammed, Straightforward ladder sequencing of peptides using a Lys-N metalloendopeptidase, Nat. Methods 5 (2008) 405-407. (Pubitemid 351619098)
28. R.J. Bateman, G. Wen, J.C. Morris, D.M. Holtzman, Fluctuations of CSF amyloidbeta levels: implications for a diagnostic and therapeutic biomarker, Neurology 68 (2007) 666-669. (Pubitemid 46667813)